BAIBYS Fertility
AI and robotics-based autonomous sperm selection for IVF.
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | €0.0 | round | |
* | $4.5m | Series A | |
| Total Funding | 000k | ||
Related Content
Baibys is a pioneering company in the field of assisted reproductive technology, focusing on the development of an automated AI-based sperm selection system. This system leverages machine vision (MV) and artificial intelligence (AI) to analyze living sperm cells in real-time, evaluating them based on morphological criteria that can only be identified using high magnification. The primary objective is to automatically select the sperm cell with the highest fertilization potential for microinjection into the egg, thereby increasing the chances of successful fertilization.
Baibys serves fertility clinics and medical professionals specializing in reproductive health. The company operates in the global fertility market, which is experiencing significant growth due to increasing infertility rates and advancements in reproductive technologies. Baibys' business model is centered around providing its AI-driven technology as a service to fertility clinics, generating revenue through service fees and potential licensing agreements.
Baibys has successfully completed a seed round funding of $1.5M and has received grant support from the Israeli Innovation Authority. The company was also selected for the Hadassah Accelerator, highlighting its innovative approach and potential in the fertility technology sector.
Keywords: AI-based sperm selection, assisted reproductive technology, machine vision, real-time analysis, high magnification, fertility clinics, reproductive health, automated system, fertilization potential, innovative technology.